Micro-compounding refers to the mixing or processing of polymer formulations in the melt on a very small scale, typically several ml. The advantage of the use of a micro-compounder for R&D are significant: it gives faster, more and yet reliable results with much smaller samples and at much less investment costs, thus speeding up the innovation process in R&D of polymer materials, pharmaceutical, biomedical and nutritional applications.
Micro-compounding is typically performed with a table top, twin screw micro-compounder or -extruder with a working volume of 5 or 15 ml. With such small volumes it is almost impossible to have sufficient mixing in a continuous extruder. Therefore, state of the art micro-compounders have a batch mode (recirculation) and a conical shape. The L/D of a continuous twin screw extruder is mimicked in a batch micro-compounder by the recirculation mixing time, which is controlled by a manual valve. With this valve the recirculation can be interrupted to unload the formulation in either a strand, or an injection moulder, a film device or a fiber line. Typical recirculation times are 1-3 min, dependent on the ease of dispersive and distributive mixing of the formulation.
With such table top laboratory equipment it is now also possible to produce films, fibers and test samples (rods, rings, tablets) from mixtures as small as 5 ml in less than 10 min. By the small footprint less lab space is needed than for a parallel twin screw extruder. Because of these benefits screening of optimum formulations in R&D is really feasible and affordable.  In pharmaceutical and biomedical R&D, where sample costs are a key issue, an easy to clean, 2 to 5 ml GMP compliant pharma micro-extruder was developed. This equipment is used for testing the improvement of bioavailability of poorly soluble drugs or realizing sustained release of dispersed or dissolved APIs. As pharmaceutical formulations are usually difficult to feed because of fluffy, static powders, this pharma micro-extruder has special options to easily fill and easily clean, which further speeds up the R&D process.
- Qizheng Dou, Xiaomin Zhu, Karin Peter, Dan E. Demco, Martin Möller, Claudiu Melian, J. Sol-Gel Sci Technol (2008) 48: 51-60
- Stretz HA, Paul DR, Polymer (2006), doi: 10.1016/j.polymer.2006.10.013
- Ozkoc, G., Bayram, G. and Tiesnitsch, J. (2008), Microcompounding of organoclay–ABS/PA6 blend-based nanocomposites. Polym Compos, 29: 345–356. doi: 10.1002/pc.20392
- Ozkoc, G., Kemaloglu, S. and Quaedflieg, M. (2010), Production of poly(lactic acid)/organoclay nanocomposite scaffolds by microcompounding and polymer/particle leaching. Polymer Composites, 31: 674–683. doi: 10.1002/pc.20846
- Özkoç, G., Bayram, G. and Quaedflieg, M. (2008), Effects of microcompounding process parameters on the properties of ABS/polyamide-6 blends based nanocomposites. Polym Compos, J. Appl. Polym. Sci., 107: 3058–3070. doi: 10.1002/app.27460
- Markus Thommes, APV Drug Delivery Focus Group Newsletter - 1/2012
- Pharmaceutical Extrusion Technology, ed. Isaac Ghebre-Sellassie, Charles Martin, Drugs and the Pharmaceutical Sciences, Volume 133, Informa Healthcare, 2007
- V. M. Litvinov, S. Guns, P. Adriaensens, B. J. R. Scholtens, M. P. Quaedflieg, R. Carleer, and G. Van den Mooter, Solid State Solubility of Miconazole in Poly[(ethylene glycol)-g-vinyl alcohol] Using Hot-Melt Extrusion., Mol. Pharmaceutics, 2012, 9 (10), pp 2924–2932 DOI: 10.1021/mp300280k
- Toshiro Sakai, presentation APV Experts‘ Workshop on Hot Melt Extrusion – Ludwigshafen, 6th November, 2012
- Toshiro Sakai and Markus Thommes, J.Pharmacy and Pharmacology 2013; DOI: 10.1111/jphp.12085